ロード中...
Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation
α7 nicotinic acetylcholine receptors (nAChRs) are relevant therapeutic targets for a variety of disorders including neurodegeneration, cognitive impairment, and inflammation. Although traditionally identified as an ionotropic receptor, the α7 subtype showed metabotropic-like functions, mainly linked...
保存先:
| 出版年: | Eur J Med Chem |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6492555/ https://ncbi.nlm.nih.gov/pubmed/30342362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmech.2018.10.015 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|